Abstract
Arterial aging, marked by progressive vascular stiffening, is a contributor to cardiovascular disease. Photoplethysmography (PPG) waveforms offer an easily accessible signal of arterial function, enabling scalable assessment of arterial age at the population level. Here, we present a multimodal deep learning framework integrating raw PPG waveforms with hemodynamic features from UK Biobank participants to construct an arterial aging clock. From this model, we derived ArtAgeGap, an age-independent residual biomarker of arterial aging, which correlated with established measures of vascular stiffening, such as pulse pressure (r=0.60). ArtAgeGap was significantly elevated in individuals with a history of cardiovascular disease, and associated with diabetes (+0.93 years, 95%CI: 0.64-1.21) and hyperlipidemia (+0.49, [0.36-0.61]). In 96,615 participants followed for a median of 13 years, higher ArtAgeGap values predicted incident hypertension, major adverse cardiovascular events, and cardiovascular and all-cause mortality (hazard ratios per +1 year: 1.01-1.06), on top of chronological age. A genome-wide association study in 114,098 individuals identified 60 independent loci associated with ArtAgeGap, including variants previously associated with blood pressure (e.g. NPR3), arterial stiffness (CLCN6), aortic diameter (SLC24A3), and atherosclerosis (HDAC9), as well as 34 novel loci enriched for arterial tissue expression. Integrative analyses with transcriptomic data from human arteries prioritized 28 genes, such as RSG19 and ULK4, whose genetically proxied expression was associated with ArtAgeGap. Single-cell transcriptomic data from arterial tissue revealed strong enrichment of these genes in fibroblasts, implicating fibrotic remodeling mechanisms in arterial aging. Rare variant burden testing further implicated damaging variants in COL21A1, LMNA, TP53BP2, RXRB, and FLOT2, also converging to mechanisms related to extracellular matrix organization and fibrosis regulation. Lastly, Mendelian randomization analysis identified ArtAgeGap as an intermediate biomarker in-between vascular risk factors and outcomes, with central adiposity, higher blood pressure, and type 2 diabetes increasing ArtAgeGap, and higher ArtAgeGap elevating the risks of coronary heart disease and stroke. Together, these findings establish ArtAgeGap as a scalable PPG-based biomarker of arterial aging and provide mechanistic insights into potential therapeutic strategies to mitigate arterial aging.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the German Research Foundation (DFG; Emmy Noether grant GZ: GE 3461/2-1, ID 512461526 to M.K.G.), the Fritz-Thyssen Foundation (grant reference number 10.22.2.024MN to M.K.G.), the Munich Cluster for Systems Neurology (EXC 2145 SyNergy, ID 390857198 to M.K.G.), and the Hertie Foundation (Hertie Network of Excellence in Clinical Neuroscience, ID P1230035 to M.K.G.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Individual-level data and genome data from UK Biobank (application number :36993, 7089, and 151281) are available under controlled access to protect participant confidentiality and in line with consent agreements. Approved researchers can apply for access through the UK Biobank data access framework (https://www.ukbiobank.ac.uk/enable-your-research/apply-for-access). The full dataset is hosted on the UK Biobank Research Analysis Platform (https://www.ukbiobank.ac.uk/enable-your-research/research-analysis-platform). GWAS summary statistics for ArtAgeGap will be made publicly available through the GWAS Catalog.
